Our portfolio company RESISTELL, which develops the world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) program.
FOLLOW ALPANA NEWS:
SWITZERLAND
Tour de l’Ile 1
CH – 1204 Geneva
+41 22 312 20 50
SILICON VALLEY, USA
Via Regina
Saratoga CA 95070
+1 408 644 8104
Copyright 2021 by ALPANA VENTURES